Twelve European Countries Getting Influenza Pandemic Prep from GSK

GSK has signed an agreement with the European Commission’s Health Emergency Preparedness and Response Authority (HERA) to help prepare 12 European countries for future influenza pandemics. The agreement is another win for the pharma giant, which signed similar deals with the US, Canada, and the World Health Organization. The total amount of pandemic influenza vaccines promised in the deals reaches 200 million.

According to Zoey Becker, “Vaccines grew GSK’s sales by 3% this quarter, and demand for its vaccine portfolio led the company to increase its sales growth outlook from between 5% and 7% to between 6% and 8%. GSK CEO Emma Walmsley called her company’s overall vaccines business a ‘real strategic strength’ in yesterday’s second-quarter earnings call.”

To read more, click here.

(Source: Fierce Pharma, July 28th, 2022)